Intec Pharma Ltd.
10 Hartom Street (Rmpe Building)
P.O.Box 45219
Jerusalem
91450
Tel: 00972-2-5864657
Fax: 00972-2-5869176
Website: http://www.intecpharma.com/
Email: info@intecpharma.com
110 articles about Intec Pharma Ltd.
-
Intec Pharma Ltd. Receives An IRB Approval To Initiate Phase III Clinical Trial Of AP - CDLD For The Treatment Of Parkinson's Disease
12/15/2015
-
Intec Pharma Ltd. Enters Phase I Clinical Trial With Its Third Pipeline Product
12/9/2015
-
Intec Pharma Ltd. Reports Results For The Third Quarter of 2015
11/9/2015
-
Intec Pharma Ltd. Expands Intellectual Property With A New Patent For The Accordion Pill In Europe
10/22/2015
-
Intec Pharma Ltd. Announces Topline Results Of A Food Effect, Pharmacokinetic Study Of AP-CDLD 50/500mg For The Treatment Of Parkinson's Disease Symptoms
10/14/2015
-
Intec Pharma Ltd. Announces Partial Exercise Of Underwriters Option To Purchase Additional Ordinary Shares
9/21/2015
-
Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering
8/10/2015
-
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering
8/4/2015
-
Intec Pharma Ltd. And IMPAX Laboratories, Inc. To Collaborate On CNS Drug Using Accordion Pill(TM) Gastric Retention Technology
6/27/2006
-
Intec Pharma Ltd. Collaborates With BioEnvelop Technologies And Tapemark - Gears Up Large-Scale Manufacturing Of SuperGeneric Drugs Using Accordion Pill(TM) Gastric Retention Technology
6/15/2006